On the other hand, in patients ≥65 years, a PSA of ≥5.3 μg/L resulted in a PPV of about 50%, while a PSA of <3.7 μg/L resulted in a NPV of 88.8%, suggesting that advanced PCa could be excluded [46]. This evidence concerns the gene KLK3 and posterior cortical atrophy.